Definition And ILAR Classification Criteria
- Juvenile-onset spondyloarthritis characterized by inflammation of joints and entheses.
- Accounts for 10-20% of juvenile idiopathic arthritis (JIA) cases globally, reaching up to 35% in Indian populations.
Table 1: ILAR Diagnostic Criteria For ERA
| Primary Requirement | Plus Minimum Two Secondary Features (If both Arthritis and Enthesitis not present) | Exclusion Criteria |
|---|---|---|
| Arthritis AND Enthesitis | Sacroiliac tenderness or inflammatory lumbosacral pain | Psoriasis in patient or first-degree relative |
| OR | HLA-B27 antigen positivity | Systemic JIA features |
| Arthritis OR Enthesitis | Arthritis onset in male older than 6 years | Positive IgM rheumatoid factor (RF) |
| Acute symptomatic anterior uveitis | ||
| First-degree relative with HLA-B27 associated disease (ankylosing spondylitis, reactive arthritis, inflammatory bowel disease) |
Epidemiology And Pathogenesis
- Predominantly affects males (male:female ratio 3.4:1 to 7:1).
- Mean age at onset 10-13 years.
- Strong genetic association with HLA-B27 antigen, positive in 50-90% of patients.
- Pathogenesis involves IL-23/IL-17 pathway activation.
- Arthritogenic peptide hypothesis suggests HLA-B27 presents joint-specific peptides to autoreactive T-cells mimicking enteric bacteria (Salmonella, Shigella).
- Misfolding hypothesis proposes HLA-B27 heavy chains accumulate in endoplasmic reticulum initiating pro-inflammatory stress response.
Clinical Features
Articular Manifestations
- Insidious onset with intermittent musculoskeletal pain and stiffness.
- Asymmetric oligoarthritis predominantly involving large joints of lower extremities (knees, ankles, hips).
- Midfoot arthritis (tarsitis) highly specific, causing profound pain and swelling.
- Hip involvement frequent at presentation, marking poor prognosis.
Enthesitis
- Exquisite point tenderness at tendon, ligament, or fascia insertion sites.
- Most frequent sites: Achilles tendon insertion, plantar fascia insertion on calcaneus.
- Knee sites: Tibial tuberosity, superior and inferior poles of patella (2, 6, 10 o'clock positions).
Axial Involvement
- Develops progressively, initially presenting as inflammatory back pain.
- Pain worsens with rest, awakens patient at night, improves with exercise.
- Sacroiliitis elicited by pelvic compression or sacroiliac distraction.
- Restricted thoracolumbar mobility assessed via modified Schober test (expansion <5 cm).
Extra-Articular Manifestations
- Acute symptomatic anterior uveitis: Presents with red, painful eye, photophobia, blurred vision.
- Uveitis typically unilateral, recurrent, resolving without long-term damage.
Diagnostic Investigations
Laboratory Parameters
- Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) normal to moderately elevated.
- HLA-B27 testing highly supportive, tested via flow cytometry or polymerase chain reaction.
- Antinuclear antibodies (ANA) and rheumatoid factor (RF) consistently negative.
Imaging Modalities
- Magnetic resonance imaging (MRI) remains gold standard for early detection.
- MRI pelvis with contrast detects active sacroiliitis, demonstrating bone marrow edema, osteitis, capsulitis.
- Ultrasound localizes structural enthesopathy, increased vascularity, soft tissue swelling.
- Conventional radiographs show late irreversible changes: joint space narrowing, subchondral sclerosis, syndesmophyte formation (bamboo spine).
Management Principles
Pharmacotherapy
- Non-steroidal anti-inflammatory drugs (NSAIDs): First-line therapy for symptomatic relief of arthritis and enthesitis (Naproxen, Indomethacin).
- Intra-articular corticosteroid injections: Triamcinolone hexacetonide targeted for isolated peripheral joint flares.
- Conventional synthetic DMARDs (csDMARDs): Sulfasalazine (40-50 mg/kg/day) preferred over methotrexate for peripheral arthritis and enthesitis. Methotrexate ineffective for axial disease.
- Biologic DMARDs (bDMARDs): Tumor necrosis factor (TNF) inhibitors (Adalimumab, Etanercept) mandated for active sacroiliitis, axial disease, or refractory peripheral arthritis.
- Adalimumab preferred over etanercept if associated uveitis present.
Rehabilitation
- Aggressive physical therapy preventing flexion contractures and postural deformities.
- Deep breathing exercises maintaining chest expansion.
- Custom orthotics alleviating focal entheseal pain.
Prognosis And Complications
- Exhibits poorer long-term outcome compared to oligoarticular JIA.
- High risk of progression to ankylosing spondylitis in adulthood.
- Complications include fixed flexion deformities, severe hip joint destruction requiring arthroplasty, atlantoaxial subluxation.